MCK insider trading
NYSE HealthcareMCKESSON CORP — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About MCKESSON CORP
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners to address challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver solutions to help people get the medicine needed to live healthier lives; and provides medication access and affordability, prescription decision support, prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services, as well as electronic prior authorization services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, biomedical maintenance, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, post-acute care facilities, hospital reference labs, and home health care agencies. The International segment delivers medicines, supplies, and information technology solutions to retail pharmacies, hospitals, long-term care centers, clinics and institutions; and provides logistics and distribution services for manufacturers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Company website: www.mckesson.com
MCK insider activity at a glance
FilingIQ has scored 987 insider transactions for MCK since Jan 22, 2015. The most recent filing in our index is dated Mar 2, 2026.
Across the full history, 0 open-market purchases
and 317 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on MCK insider trades is 66.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest MCK Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
13F funds holding MCK
Politicians who have traded MCK
Frequently asked
- How many insider trades does FilingIQ track for MCK?
- FilingIQ tracks 987 Form 4 insider transactions for MCK (MCKESSON CORP), covering filings from Jan 22, 2015 onwards. 3 of those were filed in the last 90 days.
- Are MCK insiders net buyers or net sellers?
- Across the full Form 4 history for MCK, 0 transactions (0%) were open-market purchases and 317 (32%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does MCK insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is MCK in?
- MCKESSON CORP (MCK) is classified in the Healthcare sector, specifically Medical Distribution, with a current market capitalisation of $116.92B.
Methodology & sources
Every MCK insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.